Search Results 501-510 of 17063 for Jacobson

  1. Patient Stories - Adam K. Jacob, M.D. - Mayo Clinic

    We are transforming healthcare! ... Make a gift now to help create new and better solutions for the more than 1.3 million patients who turn to Mayo Clinic each ...

  2. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

    Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, ...

  3. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  4. Publications - Bruce E. Pollock, M.D. - Mayo Clinic

    2014 May; 74: (5)466-74; discussion 474. View PubMed; Brown PD, Blanchard M, Jethwa K, Flemming KD, Brown CA, Kline RW, Jacobson DJ, St Sauver J, Pollock BE ...

  5. Ultrasound-Guided Costoclavicular Block in Patients With a BMI > 30 - Mayo Clinic

    About this study. The Researchers are trying to determine if Costoclavicular brachial plexus block (CCBPB) can be successfully performed in patients with a ...

  6. A Study to Assess Frailty and Its Impact on Patients with Pulmonary Hypertension - Mayo Clinic

    The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.

  7. Dr. Matthew Tollefson Archives - Mayo Clinic News Network

  8. A study to create and analyze a comprehensive longitudinal resource using testing results from those with genetic risk of Alzheimer's disease - Mayo Clinic

    About this study. This study aims to establish, use, and extensively share a comprehensive longitudinal resource of genetic, non-genetic, and cognitive data ...

  9. A Study of INCB039110 in Combination with Corticosteroids for the Treatment of Acute Graft Versus Host Disease - Mayo Clinic

    The purpose of this study is to determine if INCB039110 in combination with corticosteroids is safe and tolerable for treating patients with Grade IIB-IVD acute ...

  10. Testing the Addition of a New Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Rituximab) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma - Mayo Clinic

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...